Gujarat Terce cash falls Rs 194.40 lakh after investment spending

Gujarat Terce Laboratories Limited ended 30 September 2026 with cash and cash equivalents of Rs 91.58 lakh, down Rs 194.40 lakh from Rs 285.98 lakh at 31 March 2026, after Rs 485.18 lakh of current-investment purchases and Rs 125.21 lakh of short-term borrowing repayments exceeded its Rs 390.32 lakh operating cash inflow.

Why did Gujarat Terce's cash balance fall in the half year?

Gujarat Terce's cash balance fell because its Rs 584.72 lakh combined investing and financing outflows exceeded the Rs 390.32 lakh generated by operating activities in the half year ended 30 September 2026. Net cash used in investing activities was Rs 452.53 lakh and net cash used in financing activities was Rs 132.19 lakh, resulting in a Rs 194.40 lakh decrease in cash and cash equivalents.

Cash and cash equivalents declined to Rs 91.58 lakh at 30 September 2026 from Rs 285.98 lakh at the beginning of the period. The cash-flow statement compares that six-month movement with a Rs 208.04 lakh increase in cash and cash equivalents for the full year ended 31 March 2026, when closing cash was Rs 285.98 lakh.

The largest reported cash use was Rs 485.18 lakh for purchases of current investments during the half year. This compares with Rs 83.64 lakh shown for purchases or sales of current investments in the year ended 31 March 2026, although the two periods differ in length and therefore are not directly comparable.

How did Gujarat Terce generate Rs 390.32 lakh of operating cash?

Gujarat Terce generated Rs 390.32 lakh of net cash from operating activities in the half year ended 30 September 2026, after paying Rs 8.10 lakh of income tax. Profit before tax was Rs 1.47 crore, while depreciation and amortisation of Rs 21.14 lakh and finance costs of Rs 6.98 lakh were among adjustments that produced operating profit before working-capital changes of Rs 141.54 lakh.

Working-capital movements lifted cash generated from operations to Rs 398.42 lakh before tax payments. Trade payables increased by Rs 250.72 lakh, other current liabilities increased by Rs 182.19 lakh and inventories decreased by Rs 80.74 lakh, partly offset by a Rs 74.56 lakh increase in trade receivables and a Rs 182.21 lakh increase in other current assets.

The operating cash result also reflected a Rs 24.72 lakh net gain on current investments, which was deducted in arriving at operating profit before working-capital changes and shown within investing inflows. For the full year ended 31 March 2026, net cash from operating activities was Rs 171.47 lakh, compared with Rs 390.32 lakh for the six months ended 30 September 2026.

What did investment and financing cash flows do to Gujarat Terce's liquidity?

Gujarat Terce used Rs 452.53 lakh in investing activities, primarily because purchases of current investments totalled Rs 485.18 lakh. Offsetting investing inflows included Rs 7.74 lakh of interest received, Rs 1.25 lakh of rental income and Rs 24.72 lakh of net gains on current investments, while tangible-asset purchases were Rs 10,000.

Current investments on the balance sheet rose to Rs 6.20 crore at 30 September 2026 from Rs 1.35 crore at 31 March 2026. The Rs 4.85 crore increase in that balance broadly corresponds with the Rs 4.85 crore cash-flow line for current-investment purchases, while the filing separately records investment gains and other investing cash flows.

Financing activities used Rs 132.19 lakh, including a Rs 125.21 lakh repayment of short-term borrowings and Rs 6.98 lakh of finance costs. In contrast, financing activities generated Rs 47.36 lakh in the year ended 31 March 2026, supported by Rs 1.05 crore of equity-share issue proceeds and a Rs 84.28 lakh increase in short-term borrowings.

How did Gujarat Terce's balance sheet change by September?

Gujarat Terce reported total current assets of Rs 19.08 crore at 30 September 2026, compared with Rs 14.41 crore at 31 March 2026. Alongside the increase in current investments to Rs 6.20 crore, trade receivables rose to Rs 5.61 crore from Rs 4.87 crore and loans rose to Rs 3.26 crore from Rs 1.43 crore.

Inventories fell to Rs 2.92 crore at 30 September 2026 from Rs 3.73 crore at 31 March 2026, while cash and cash equivalents fell to Rs 91.58 lakh from Rs 285.98 lakh. Other bank balances were unchanged at Rs 17.33 lakh across the two balance-sheet dates.

Total current liabilities increased to Rs 14.31 crore at 30 September 2026 from Rs 10.95 crore at 31 March 2026. Short-term borrowings declined to Rs 86.95 lakh from Rs 1.27 crore, while trade payables to creditors other than micro and small enterprises rose to Rs 6.34 crore from Rs 1.68 crore.

What do Gujarat Terce's half-year earnings show alongside cash movement?

Gujarat Terce reported revenue from operations of Rs 21.78 crore for the half year ended 30 September 2026, down from Rs 23.78 crore in the corresponding half year ended 30 September 2025. Total revenue declined to Rs 22.37 crore from Rs 23.93 crore, and profit after tax fell to Rs 1.14 crore from Rs 1.36 crore.

The company operates in a single pharmaceutical segment, so the filing does not provide separate segment cash flows or investment allocations. Purchases of stock in trade were Rs 6.29 crore in the 2026 half year versus Rs 5.34 crore a year earlier, while employee-benefit expenses were Rs 7.99 crore compared with Rs 7.91 crore.

The board approved the unaudited standalone results on 5 November 2026. Shah Doshi Patel & Associates LLP completed a limited review and stated that nothing had come to its attention indicating that the half-year results contained a material misstatement.

Conclusion

Gujarat Terce's Rs 194.40 lakh cash reduction in the half year ended 30 September 2026 followed Rs 4.85 crore of current-investment purchases and Rs 125.21 lakh of short-term borrowing repayments. Operating activities generated Rs 390.32 lakh, but this did not cover the Rs 452.53 lakh investing outflow and Rs 132.19 lakh financing outflow.

The filing does not disclose a future investment target, borrowing plan or cash-balance target. Subsequent financial disclosures will show whether the Rs 6.20 crore current-investment balance, Rs 5.61 crore trade receivables and Rs 6.34 crore trade payables at 30 September 2026 change further.